Omaxe

Which are the latest news on Omaxe?

Why is Omaxe Ltd falling/rising?

As of 27-Jun, Omaxe Ltd's stock price is 77.54, showing a slight increase but a significant decline of -25.74% over the past year. Despite some institutional interest, the company's negative financial indicators and declining retail participation indicate substantial challenges ahead.

As of 27-Jun, Omaxe Ltd's stock price is currently at 77.54, reflecting a slight increase of 0.11 (0.14%). Despite this minor rise, the stock has shown a significant decline over the past year, with a return of -25.74%, which is considerably worse than the broader market's performance, as indicated by the BSE500's negative return of -1.13% during the same period.<BR><BR>The stock's recent performance shows mixed signals. Over the past week, it has decreased by -0.15%, while it has gained +0.98% over the past month, outperforming the Sensex, which rose by only +0.80%. However, the year-to-date performance remains poor, with a decline of -6.43% compared to the Sensex's -9.53%.<BR><BR>Investor participation has also been declining, as evidenced by a significant drop in delivery volume, which fell by -66.93% against the 5-day average. This suggests that retail investors may be losing interest in the stock. On the other hand, there has been an increase in institutional investor participation, with a 1.07% rise in their stake over the previous quarter, indicating some level of confidence from more sophisticated investors.<BR><BR>However, the company's fundamentals are concerning. It has a negative book value and has reported negative operating profit growth of -240.34% over the last five years. The company has also declared negative results for the last four consecutive quarters, with a high Debt to EBITDA ratio of -2.11 times, indicating a low ability to service its debt. The negative EBITDA of Rs. -695.83 cr further highlights the company's financial struggles.<BR><BR>In summary, while there is a slight uptick in the stock price and some institutional interest, the overall negative financial indicators and declining retail investor participation suggest that Omaxe Ltd is facing significant challenges, contributing to its overall poor performance in the market.

How big is Omaxe?

As of 10th June, Omaxe Ltd has a market capitalization of 1,360.00 Cr and reported Net Sales of 1,253.40 Cr, but incurred a Net Profit loss of 696.86 Cr over the latest four quarters. The company has Shareholder's Funds at a loss of 205.13 Cr and Total Assets of 14,265.08 Cr.

As of 10th June, Omaxe Ltd has a market capitalization of 1,360.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Omaxe reported Net Sales of 1,253.40 Cr. However, the company experienced a loss of 696.86 Cr in Net Profit during the same period.<BR><BR>The latest annual reporting period for Omaxe shows Shareholder's Funds at a loss of 205.13 Cr and Total Assets amounting to 14,265.08 Cr.

Who are in the management team of Omaxe?

The management team of Omaxe includes Rohtas Goel (Chairman), Mohit Goel (Managing Director), Vinit Goyal (Whole-time Director), and several independent directors: Gurnam Singh, Shridhar Rao, and Nishal Jain, along with Vikas Khandelwal as Company Secretary. They oversee the company's operations and strategic direction.

The management team of Omaxe includes the following individuals:<BR><BR>1. **Rohtas Goel** - Chairman & Wholetime Director<BR>2. **Mohit Goel** - Managing Director<BR>3. **VINIT GOYAL** - Whole-time Director<BR>4. **Gurnam Singh** - Independent Director<BR>5. **Shridhar Rao** - Independent Director<BR>6. **Nishal Jain** - Independent Director<BR>7. **Vikas Khandelwal** - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the company's operations and strategic direction. If you have any more questions about Omaxe or its management, feel free to ask!

Who are the peers of the Omaxe?

Omaxe's peers include Ajmera Realty, Alembic, Arkade, Meghna Infracon, Shriram Properti, Unitech, Arihant Super, Suraj Estate, B-Right Real, and Laxmi Goldorna. Omaxe has below average management risk and growth, with a 1-year return of -19.98%, better than Unitech but worse than B-Right Real's 135.56%.

Peers: The peers of Omaxe are Ajmera Realty, Alembic, Arkade, Meghna Infracon, Shriram Properti, Unitech, Arihant Super., Suraj Estate, B-Right Real, and Laxmi Goldorna.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alembic, while Average management risk is found at Ajmera Realty, Arkade, Meghna Infracon, and Suraj Estate, and the rest. Below Average management risk is present at Omaxe, Shriram Properti, Unitech, B-Right Real, and Laxmi Goldorna. Growth is Excellent at Alembic, Good at Ajmera Realty, Average at Meghna Infracon, Arihant Super., and Suraj Estate, while Below Average growth is noted at Omaxe, Shriram Properti, Unitech, Arkade, and B-Right Real. Capital Structure is Excellent at Alembic, while Average is found at Suraj Estate, and Below Average at Omaxe, Ajmera Realty, Shriram Properti, Unitech, Arkade, Arihant Super., B-Right Real, and Laxmi Goldorna.<BR><BR>Return Snapshot: The peer with the highest 1-year return is B-Right Real at 135.56%, while the lowest is Unitech at -49.79%. Omaxe's 1-year return of -19.98% is better than Unitech's but worse than B-Right Real's. Additionally, the six-month return is negative for Ajmera Realty, Alembic, Arkade, Shriram Properti, Unitech, Suraj Estate, and Arihant Super.

What does Omaxe do?

Omaxe Ltd is a micro-cap realty company focused on construction and contracting, with a recent quarterly net sales of ₹349 Cr and a net loss of ₹191 Cr. Founded in 1989, it became a public company in 1999 and has a market cap of ₹1,360 Cr.

Overview: <BR>Omaxe Ltd is a micro-cap company operating in the realty industry, primarily engaged in construction and contracting.<BR><BR>History: <BR>Omaxe Limited was incorporated in 1989 as Omaxe Construction Private Limited. It transitioned to a public limited company in 1999 and changed its name to Omaxe Limited in 2006. The latest reported quarter for net sales and profit is March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 349 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: -191 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 1,360 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 33 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.62 <BR>Return on Equity: 77.30% <BR>Price to Book: -1.51 <BR><BR>Contact Details: <BR>Address: Shop 19-B First Floor Sohna Rd, Omaxe Celebration Mall Gurgaon Haryana : 122001 <BR>Tel: 91-11-41896680-85/41896676/4189679 <BR>Email: sales@omaxe.com/vrr@omaxe.com <BR>Website: http://www.omaxe.com

Are Omaxe Ltd latest results good or bad?

Omaxe Ltd's latest results are concerning, showing a net loss of ₹191.30 crores in Q4 FY26, marking the sixth consecutive quarter of losses. Despite a slight revenue increase, the company's significant operational inefficiencies and negative shareholder funds indicate serious financial challenges.

Omaxe Ltd's latest results indicate a challenging situation for the company. In Q4 FY26, Omaxe reported a net loss of ₹191.30 crores, which is a significant decline of 28.98% year-over-year and 24.87% quarter-over-quarter. This marks the sixth consecutive quarter of losses, highlighting ongoing operational difficulties.<BR><BR>While there was a sequential improvement in revenue, which increased by 15.47% from the previous quarter to ₹348.52 crores, this figure is still down 35.61% compared to the same quarter last year. The operating margin, excluding other income, deteriorated to -57.94%, a stark decline from -19.59% in Q4 FY25, indicating severe operational inefficiencies.<BR><BR>The company's balance sheet is also concerning, with negative shareholder funds of ₹-205.13 crores and a negative book value of ₹-23.53 per share. This situation raises significant questions about the company's financial stability and future viability.<BR><BR>Overall, the results reflect a company in distress, facing critical operational and financial challenges that require urgent strategic intervention. Investors should be cautious, as the outlook appears grim with ongoing losses and a lack of institutional support.

Should I buy, sell or hold Omaxe Ltd?

How has been the historical performance of Omaxe?

Omaxe's historical performance shows fluctuating net sales, peaking at 1,614.32 Cr in March 2024 but declining to 1,560.99 Cr in March 2025, alongside significant losses, with profit after tax dropping to -685.13 Cr. The company faces increasing liabilities and a challenging financial environment, despite a slight improvement in cash flow from operations.

Answer:<BR>The historical performance of Omaxe shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods.<BR><BR>Breakdown:<BR>Omaxe's net sales peaked at 1,614.32 Cr in March 2024 but declined to 1,560.99 Cr in March 2025. The total operating income followed a similar pattern, reaching 1,614.32 Cr in March 2024 and then decreasing to 1,560.99 Cr in March 2025. The company faced substantial challenges, reflected in its operating profit (PBDIT), which fell to -531.76 Cr in March 2025 from -322.70 Cr in March 2024. Profit before tax also worsened, dropping to -763.75 Cr in March 2025 from -507.30 Cr in the previous year. Consequently, profit after tax showed a similar decline, resulting in a loss of -685.13 Cr in March 2025 compared to -406.14 Cr in March 2024. The company's total liabilities increased to 14,265.08 Cr in March 2025, up from 13,291.67 Cr in March 2024, while total assets also rose to 14,265.08 Cr. Cash flow from operating activities improved slightly to 1,006.00 Cr in March 2025, compared to 986.00 Cr in March 2024, but cash flow from financing activities remained negative at -770.00 Cr. Overall, Omaxe's financial performance indicates a challenging environment with increasing losses and a rising debt burden.

Is Omaxe technically bullish or bearish?

As of 27 October 2025, Omaxe's technical trend has shifted to bearish, with strong indications of weakness supported by bearish MACD, moving averages, and KST, despite some divergence shown by a bullish OBV on the monthly timeframe.

As of 27 October 2025, the technical trend for Omaxe has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly and monthly MACD are both bearish, reinforcing the negative outlook. The daily moving averages also confirm a bearish trend. Additionally, the KST is bearish on both weekly and monthly time frames. While the Bollinger Bands indicate a mildly bearish stance, the OBV shows a bullish trend on the monthly, suggesting some divergence. Overall, the bearish indicators dominate, reflecting a weak technical position for Omaxe.

When is the next results date for Omaxe?

The next results date for Omaxe is 13 August 2025.

The next results date for Omaxe is scheduled for 13 August 2025.

Who are the top shareholders of the Omaxe?

The top shareholders of Omaxe include Guild Builders Pvt Ltd with 63.57%, foreign institutional investors holding 7.38%, and Unico Global Opportunities Fund Limited as the largest public shareholder with 3.48%. Individual investors own 11.17%, and there are no mutual funds currently invested in Omaxe.

The top shareholders of Omaxe include the promoters, who hold the majority of the shares. The promoter with the highest holding is Guild Builders Pvt Ltd, which owns 63.57% of the company. Additionally, foreign institutional investors (FIIs) hold 7.38% of the shares, represented by 10 different FIIs. The highest public shareholder is Unico Global Opportunities Fund Limited, with a stake of 3.48%. Individual investors collectively hold 11.17% of the shares. It's worth noting that there are currently no mutual funds holding shares in Omaxe.

Is Omaxe overvalued or undervalued?

As of November 13, 2020, Omaxe is considered overvalued and in a risky financial position due to negative valuation ratios, despite a recent stock return of 45.66%, contrasting sharply with its long-term performance of -47.56% compared to the Sensex's 142.99%.

As of 13 November 2020, the valuation grade for Omaxe has moved from expensive to risky, indicating a shift in perception regarding its financial health. The company is currently considered overvalued, given its negative PE ratio of -2.68, a price-to-book value of -8.97, and an EV to EBITDA ratio of -3.11. These ratios suggest significant financial distress, particularly with negative returns on capital employed and equity.<BR><BR>In comparison to its peers, Omaxe stands out with a notably lower PEG ratio of 0.00, while competitors like DLF and Macrotech Development are categorized as very expensive, with PE ratios of 46.64 and 54.71, respectively. The stark contrast in valuations highlights Omaxe's precarious position in the market. Despite a recent one-month stock return of 45.66%, which outperformed the Sensex's 3.85%, the overall long-term performance remains concerning, particularly with a five-year return of -47.56% compared to the Sensex's 142.99%.

What is the bonus history of the Omaxe?

Omaxe Ltd's bonus history includes a significant issue at a ratio of 10:39, announced on November 11, 2013, where shareholders received 10 additional shares for every 39 shares held.

Omaxe Ltd has a bonus history that includes a significant bonus issue announced at a ratio of 10:39. This bonus was issued with an ex-date of November 11, 2013, and the record date was November 12, 2013. This means that for every 39 shares held, shareholders received an additional 10 shares. If you have any more questions about Omaxe or need further details, feel free to ask!

Has Omaxe declared dividend?

Omaxe Ltd has declared a 7% dividend, amounting to ₹0.7 per share, but the dividend yield is currently 0%. Total returns over various periods show mixed performance, with significant gains over 1 and 2 years, while the 5-year period reflects a substantial loss of -46.33%.

Omaxe Ltd has declared a 7% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 7%<BR>- Amount per share: 0.7<BR>- Ex-date: 19 Sep 19<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>Over the 6-month period, the price return was -9.24%, with a dividend return of 0%, resulting in a total return of -9.24%.<BR><BR>In the 1-year period, the price return was 16.57%, with a dividend return of 0%, leading to a total return of 16.57%.<BR><BR>For the 2-year period, the price return was 95.78%, while the dividend return remained at 0%, resulting in a total return of 95.78%.<BR><BR>During the 3-year period, the price return was 14.08%, with no dividend return, culminating in a total return of 14.08%.<BR><BR>In the 4-year period, the price return was 24.82%, and the dividend return was 0%, resulting in a total return of 24.82%.<BR><BR>Over the 5-year period, the price return was -46.33%, with a dividend return of 0%, leading to a total return of -46.33%.<BR><BR>Overall, Omaxe Ltd has declared a dividend, but the dividend yield is currently 0%. The total returns over various periods show a mix of positive and negative performance, with significant gains over 1 and 2 years, while the 5-year period reflects a substantial loss.